Reaction Details |
| Report a problem with these data |
Target | Alpha-1B adrenergic receptor |
---|
Ligand | BDBM50100216 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_34198 (CHEMBL649215) |
---|
Ki | 0.33±n/a nM |
---|
Citation | Meyer, MD; Altenbach, RJ; Bai, H; Basha, FZ; Carroll, WA; Kerwin, JF; Lebold, SA; Lee, E; Pratt, JK; Sippy, KB; Tietje, K; Wendt, MD; Brune, ME; Buckner, SA; Hancock, AA; Drizin, I Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia. J Med Chem44:1971-85 (2001) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Alpha-1B adrenergic receptor |
---|
Name: | Alpha-1B adrenergic receptor |
Synonyms: | ADA1B_HUMAN | ADRA1B | Adrenergic alpha1B | Adrenergic receptor | Adrenergic receptor alpha | Alpha 1B-adrenoceptor | Alpha 1B-adrenoreceptor | Alpha-1B adrenergic receptor |
Type: | Enzyme |
Mol. Mass.: | 56862.13 |
Organism: | Homo sapiens (Human) |
Description: | P35368 |
Residue: | 520 |
Sequence: | MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAI
VGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDI
WAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGP
LLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAG
VMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVV
GMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFV
RILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRT
LPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLT
EPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF
|
|
|
BDBM50100216 |
---|
n/a |
---|
Name | BDBM50100216 |
Synonyms: | 3-[2-(6-Methoxy-1,3,3a,4,5,9b-hexahydro-benzo[e]isoindol-2-yl)-ethyl]-7-phenyl-1H-thieno[3,2-d]pyrimidine-2,4-dione | CHEMBL61483 |
Type | Small organic molecule |
Emp. Form. | C27H27N3O3S |
Mol. Mass. | 473.587 |
SMILES | COc1cccc2[C@@H]3CN(CCn4c(=O)[nH]c5c(csc5c4=O)-c4ccccc4)C[C@@H]3CCc12 |
Structure |
|